课题基金 / 基金详情

SUPPRESSION OF V MYB TRANSFORMATION BY RAR AND RXR

SUPPRESSION OF V MYB TRANSFORMATION BY RAR AND RXR
RAR 和 RXR 对 V MYB 转化的抑制
批准号:
2772089
负责人:
Joseph Steven Lipsick
金额:
$2.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-01 至 1999-08-31

项目摘要

项目成果

Joseph Steven Lipsick的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION The overall goal of this proposal is to understand the mechanism by which the retinoic acid receptor-a suppresses transformation by the v-Myb oncoprotein. v-Myb transforms monoblasts, macrophage precursors which are blocked in their ability to differentiate. However, the introduction of exogenous RAR-a into the v- Myb-transformed BM2 cell line permits macrophage differentiation in response to retinoic acid, despite the continued presence of the v-Myb protein. Because RAR generally functions as a heterodimer with an RXR protein, the role of RXR proteins in this system is a major focus for the next three-year period. The specific aims for understanding the mechanism by which RAR-a suppresses transformation by v- Myb are the following: 1) Preparation of RXR-a and RXR-a-specific monoclonal antibodies; 2) Preparation and analysis of RXR-a and RXR-a-expressing BM2 cells; 3) Determination of the effect of RAR/RXR on transcriptional activation by v-Myb, and conversely, determination of the effect of v-Myb on transcriptional regulation by RAR/RXR; 4) Analysis of the effect of RAR/RXR upon DNA-binding by v-Myb and vice versa; 5) Analysis of the effect of RAR and RXR upon TPA-induced differentiation of BM2 cells; and 6) Identification of genes which are differentially expressed in Ra treated BM2 and BM2-RAR cells.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Retinoid X receptor suppresses transformation by the v-myb oncogene.
类视黄醇 X 受体抑制 v-myb 癌基因的转化。
DOI: 10.1002/jlb.66.6.1039
发表时间: 1999
期刊: Journal of leukocyte biology
影响因子: 5.5
作者: [Smarda,J, Zemanová,K, Bryja,J, Smardová,J, Kozubík,A, Hofmanová,J, Nemajerová,A, Sevcíková,S, Kohoutek,J, Vodicka,P]
通讯作者: Vodicka,P
Oncoprotein v-Myb and retinoic acid receptor alpha are mutual antagonists.
癌蛋白 v-Myb 和视黄酸受体 α 是相互拮抗剂。
DOI: 10.1006/bcmd.1998.0189
发表时间: 1998
期刊: Blood cells, molecules & diseases
影响因子: --
作者: [Zemanová,K, Smarda,J]
通讯作者: Smarda,J
The effects of RARalpha and RXRalpha proteins on growth, viability, and differentiation of v-myb-transformed monoblasts.
RARalpha 和 RXRalpha 蛋白对 v-myb 转化的单核细胞生长、活力和分化的影响。
DOI: 10.1006/bcmd.2000.0316
发表时间: 2000
期刊: Blood cells, molecules & diseases
影响因子: --
作者: [Vodicka,P, Sevcíková,S, Smardová,J, Soucek,K, Smarda,J]
通讯作者: Smarda,J
A possible cross-talk of retinoic acid- and TPA-driven myeloid differentiation pathways.
视黄酸和 TPA 驱动的骨髓分化途径可能存在交叉。
DOI: --
发表时间: 1998
期刊: Folia biologica.
影响因子: --
作者: [Zemanova,K, Smarda,J]
通讯作者: Smarda,J
Biology of the Myb-MuvB Oncoprotein-Tumor Suppressor Protein Complex
  • 批准号:
    7489842
  • 项目类别:
  • 资助金额:
    $29.68万
  • 财政年份:
    2007
  • 负责人:
    Joseph Steven Lipsick
  • 依托单位:
Biology of the Myb-MuvB Oncoprotein-Tumor Suppressor Protein Complex
  • 批准号:
    7858000
  • 项目类别:
  • 资助金额:
    $30.02万
  • 财政年份:
    2007
  • 负责人:
    Joseph Steven Lipsick
  • 依托单位:
Biology of the Myb-MuvB Oncoprotein Tumor Suppressor Protein Complex
  • 批准号:
    8825437
  • 项目类别:
  • 资助金额:
    $27.49万
  • 财政年份:
    2007
  • 负责人:
    Joseph Steven Lipsick
  • 依托单位:
Biology of the Myb-MuvB Oncoprotein-Tumor Suppressor Protein Complex
  • 批准号:
    7296048
  • 项目类别:
  • 资助金额:
    $29.14万
  • 财政年份:
    2007
  • 负责人:
    Joseph Steven Lipsick
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: